News | Magnetic Resonance Imaging (MRI) | July 05, 2018

High-Strength MRI May Release Mercury from Amalgam Dental Fillings

While new research suggests ultra-high-field 7T MRI could pose problems for people with amalgam fillings, conventional 1.5T scans were found to be safe

High-Strength MRI May Release Mercury from Amalgam Dental Fillings

July 5, 2018 — Exposure to ultra-high-strength magnetic resonance imaging (MRI) may release toxic mercury from amalgam fillings in teeth, according to a new study appearing online in the journal Radiology. The effect was not seen, however, in the lower strength, more commonly used 1.5-Tesla (T) MRI.

Amalgam fillings, also known as silver fillings, have been a staple of dentistry for many years. Amalgam consists of approximately 50 percent mercury, a known toxin that can cause a host of harmful effects in humans. Despite the presence of mercury, the U.S. Food and Drug Administration (FDA) considers amalgam fillings safe for adults and children older than age six.

“In a completely hardened amalgam, approximately 48 hours after placing on teeth, mercury becomes attached to the chemical structure, and the surface of the filling is covered with an oxide film layer,” said the study’s lead author, Selmi Yilmaz, Ph.D., a dentist and faculty member at Akdeniz University in Antalya, Turkey. “Therefore, any mercury leakage is minimal.”

Previous research has found that exposure to the magnetic fields of MRI could cause mercury to leak from amalgam fillings. This concern has been heightened by the recent arrival of ultra-high-strength 7T scanners in the clinic. The stronger magnetic field of 7T MRI yields more anatomical detail, but its effects on amalgam dental fillings have not been studied.

To learn more, Yilmaz and colleague, Mehmet Zahit Adişen, Ph.D., evaluated mercury released from dental amalgam after 7T and 1.5T MRI in teeth that had been extracted from patients for clinical indications. While 7T MRI was approved by the FDA in 2017, it has extremely limited availability. The lower-strength 1.5T MRI is widely available and commonly used for patient exams.

The researchers opened two-sided cavities in each tooth and applied amalgam fillings. After nine days, two groups of 20 randomly selected teeth were placed in a solution of artificial saliva immediately followed by 20 minutes of exposure to 1.5T or 7T MRI. A control group of teeth was placed in artificial saliva only.

When the researchers analyzed the artificial saliva, the mercury content in the 7T, 1.5T and control group was 0.67 ± 0.18, 0.17 ± 0.06 and 0.14 ± 0.15 parts per million (ppm), respectively.  At 0.67 ppm, the mercury content in the 7T group was approximately four times the levels found in the 1.5T group and the control group.

“In our study, we found very high values of mercury after ultra-high-field MRI,” Yilmaz said. “This is possibly caused by phase change in amalgam material or by formation of microcircuits, which leads to electrochemical corrosion, induced by the magnetic field.”

An important point of discrimination concerning safety and hazard to human health is the amount of mercury that is absorbed by the vital tissues.

“It is not clear how much of this released mercury is absorbed by the body,” Yilmaz said.

Further studies may be warranted, Yilmaz added, to evaluate the relationship between high-field MRI and release of mercury from dental amalgam. The researchers have three ongoing projects focused on phase and temperature changes of dental amalgam across different magnetic fields.

As no evidence of harmful effects was found in the 1.5T group, patients with amalgam fillings should not be unduly concerned about having an MRI exam.

For more information: www.pubs.rsna.org/journal/radiology

Reference

Yilmaz S., Adisen M.Z. "Ex Vivo Mercury Release from Dental Amalgam after 7.0-T and 1.5-T MRI," Radiology. June 26, 2018. https://doi.org/10.1148/radiol.2018172597

Related Content

Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
150-Year-Old Drug Might Improve Radiation Therapy for Cancer
News | Radiation Therapy | November 02, 2018
November 2, 2018 — A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more
SBRT Considered Safe Treatment Option for Patients With Multiple Metastases
News | Stereotactic Body Radiation Therapy (SBRT) | November 01, 2018
The NRG Oncology clinical trial BR001 tested the hypothesis that stereotactic body radiotherapy (SBRT) could be used...
Hypofractionated Radiation Provides Same Prostate Cancer Outcomes as Conventional Radiation
News | Intensity Modulated Radiation Therapy (IMRT) | October 31, 2018
An analysis led by researchers at Philadelphia’s Fox Chase Cancer Center found treating localized prostate cancer with...
Prostate Brachytherapy Shows Low Incidence of Short-Term Complications
News | Brachytherapy Systems | October 31, 2018
A new analysis of nearly 600 men receiving brachytherapy for prostate cancer shows overall procedure-related...